Skip to content
The Nexus
DossierENTITY

MIST

Coverage of MIST in the Nexus archive.

Earliest in view: Aug 12 · 11:21 UTCMost recent: Aug 12 · 11:21 UTC
Co-mentioned in this coverage
Milestone Pharmaceuticalsorganization1Zacks Investment Researchorganization1Montrealplace1$28.6 milliontopic1biotechnologytopic1
Recent coverage
  • BUSINESSAug 12 · 11:21 UTCWTOP DC
    Milestone Pharmaceuticals: Q2 Earnings Snapshot

    Milestone Pharmaceuticals Inc. reported a loss of $28.6 million and 21 cents per share for its second quarter, missing Wall Street expectations. The company also posted revenue of $559,000, which fell short of the three-analyst forecast of $800,000.

MIST · Dossier · The Nexus